Clinical Trials Logo

Clinical Trial Summary

Global Developmental Delay is a disorder characterized by failure achievement of expected milestones in different areas of psychomotor development before 5 years of age. Recent data in the literature have emphasized the importance of early therapeutic intervention. However, few specific interventions have been described in the literature for this disorder. Among the high-tech tools used in recent years for rehabilitation, the BTs Nirvana is one of the semi-immersive system that can also be used in children, which allows to stimulate cognitive and motor domains. Objective of this single-blind, randomized, controlled study is to evaluate the feasibility and the effectiveness of integrated rehabilitation treatments with the use of BTs Nirvana in patient with Global Developmental Delay.


Clinical Trial Description

Global Developmental Delay (GDD) is a disorder characterized by failure achievement of expected milestones in different areas of psychomotor development before 5 years of age. The estimated incidence of GDD is 1-3%, an early diagnosis and an efficacy treatment could provide a better long-term prognosis. Recent literature data have underlined the importance of early diagnosis followed by appropriate therapeutic management. In fact, GDDs could evolve into different neurodevelopmental disorders, especially if associated with other risk factors, such as intrauterine growth retardation, nutrient deficiencies, breastfeeding and maternal education, scarce social and economic conditions, poor learning opportunities, inadequate quality of caregiver-child interactions. In recent decades, the use of virtual reality (VR) for therapeutic reason has become more and more popular for innovative treatments in cognitive-motor domain. Indeed, VR and the interactive playing can motivate children to learn new skills. Among the high-tech tools used in recent years for rehabilitation, the BTs Nirvana (BTsN) is one of the semi-immersive VR that can also be used in children, which allows to stimulate cognitive and motor domains. The aim of this single-blind, randomized, controlled study is to evaluate the feasibility and the effectiveness of integrated rehabilitation treatments with the use of BTsN in patient with Global Developmental Delay. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05879952
Study type Interventional
Source IRCCS Centro Neurolesi "Bonino-Pulejo"
Contact Francesca Cucinotta, MD, PhD
Phone 09060128256
Email francesca.cucinotta@irccsme.it
Status Recruiting
Phase N/A
Start date December 1, 2020
Completion date September 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT04511767 - Reliability and Validity of CCISO for Diagnosis of Autism Spectrum Disorder
Completed NCT01430845 - Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Completed NCT05408351 - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Completed NCT01601158 - Umbilical Cord Blood Therapy for Children With Global Developmental Delay N/A
Completed NCT03847402 - The Early Integrated Intervention for Child Brain-developmental Disorders in China N/A
Not yet recruiting NCT05418933 - Workshops for Children With Global Developmental Delays N/A
Completed NCT01441674 - Animal Assisted Therapy in a Pediatric Setting Phase 1/Phase 2
Completed NCT01769716 - Umbilical Cord Blood Therapy for Global Developmental Delay N/A
Completed NCT04816175 - Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay N/A
Completed NCT05398900 - Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children